Internal Medicine, Cardiovascular Disease · Mobile, AL
NPI
1609822162
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1700 Springhill Ave, Suite 100
Mobile, AL, 36604
Phone (251) 435-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
9,527 services
Medicare patients, 2024
660
Average age 76
Drug cost, 2024
$2.5M
11,794 prescriptions
Company payments, 2025
$673
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hercules Panayiotou was code 99232 (hospital e&m - subsequent), 588 times for 143 patients. In total Hercules Panayiotou billed 9,527 services in 89 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 588 | 143 | $56.47 | $33K |
| 36415 Venipuncture Blood Collection | Office | 419 | 253 | $8.65 | $3,624 |
| 85025 Blood Count | Office | 403 | 258 | $7.59 | $3,061 |
| 80053 Clinical Chemistry | Office | 402 | 260 | $10.30 | $4,141 |
| 93000 Electrocardiogram | Office | 382 | 247 | $8.97 | $3,425 |
| 99214 Office E&M - Established | Office | 382 | 260 | $82.47 | $32K |
| 82550 Clinical Chemistry | Office | 356 | 254 | $6.37 | $2,268 |
| 80061 Clinical Chemistry | Office | 354 | 253 | $13.02 | $4,611 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 350 | 241 | $11.44 | $4,006 |
| 82248 Clinical Chemistry | Office | 345 | 248 | $4.92 | $1,697 |
| 83615 Clinical Chemistry | Office | 345 | 248 | $5.91 | $2,040 |
| 82977 Clinical Chemistry | Office | 339 | 242 | $7.05 | $2,389 |
| 71046 X-ray - Chest | Office | 328 | 258 | $13.75 | $4,511 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 248 | 62 | $4.96 | $1,229 |
| 93306 Echocardiography (TTE/TEE) | Office | 216 | 198 | $112.61 | $24K |
By year: 2022 $293K for 9,490 services; 2023 $277K for 9,237 services; 2024 $236K for 9,527 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 419 | 253 | $8.65 | $3,624 |
| 85025 Blood Count | 403 | 258 | $7.59 | $3,061 |
| 80053 Clinical Chemistry | 402 | 260 | $10.30 | $4,141 |
| 82550 Clinical Chemistry | 356 | 254 | $6.37 | $2,268 |
| 80061 Clinical Chemistry | 354 | 253 | $13.02 | $4,611 |
| 82248 Clinical Chemistry | 345 | 248 | $4.92 | $1,697 |
| 83615 Clinical Chemistry | 345 | 248 | $5.91 | $2,040 |
| 82977 Clinical Chemistry | 339 | 242 | $7.05 | $2,389 |
| 84443 Clinical Chemistry | 196 | 142 | $16.41 | $3,217 |
| 84439 Clinical Chemistry | 196 | 142 | $8.83 | $1,731 |
Medicare prescription drug claims, 2024
In 2024, the drug Hercules Panayiotou prescribed most often to Medicare patients was Ezetimibe, with 946 prescriptions and refills. In total Hercules Panayiotou wrote 11,794 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 946 | 2,750 | 327 | $21K |
| Atorvastatin Calcium Generic | 740 | 2,093 | 238 | $10K |
| Rosuvastatin Calcium Generic | 715 | 2,050 | 237 | $12K |
| Metoprolol Succinate Generic | 648 | 1,889 | 214 | $8,740 |
| Clopidogrel Clopidogrel Bisulfate | 625 | 1,851 | 195 | $7,716 |
| Eliquis Apixaban | 498 | 815 | 110 | $471K |
| Furosemide Generic | 498 | 1,398 | 180 | $2,501 |
| Spironolactone Generic | 425 | 1,182 | 143 | $3,400 |
| Amlodipine Besylate Generic | 415 | 1,180 | 152 | $2,792 |
| Jardiance Empagliflozin | 399 | 816 | 116 | $476K |
| Pantoprazole Sodium Generic | 353 | 1,014 | 120 | $4,305 |
| Carvedilol Generic | 325 | 842 | 95 | $2,896 |
| Levothyroxine Sodium Generic | 314 | 917 | 104 | $3,843 |
| Amiodarone Hcl Generic | 263 | 706 | 88 | $4,135 |
| Hydralazine Hcl Generic | 231 | 644 | 85 | $2,798 |
Brand drugs: - claims; generic drugs: 9,403 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hercules Panayiotou $673 ($673 in general payments such as food, travel and fees) from 10 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $174.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $174 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $165 |
| Esperion Therapeutics, Inc. ESPR | 4 | $77.66 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $60.48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $57.85 |
| Scpharmaceuticals Inc. SCPH | 2 | $38.14 |
| Pfizer Inc. PFE | 2 | $36.24 |
| Medtronic, Inc. MDT | 1 | $30.6 |
| Novo Nordisk Inc NVO | 1 | $17.69 |
| Amgen Inc. AMGN | 1 | $15.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.